RetinAI Disease Evaluation Apps - Elevating Patient Interactions with Advanced AI Insights

About

Elevate your clinical assessments with RetinAI's Disease Evaluation Applications. Specifically designed to cater to some of the most prevalent vision-threatening ailments in the field of ophthalmology such as AMD, DR, DME, CME, and GA*, our innovative applications generate easy-to-read reports swiftly during your patient consultations.

Enrich your OCT analyses with our CE-marked AI models, and share real-time, actionable insights with your patients. Perform in-depth evaluations of fluid volume, layer thickness in OCT volumes, monitor retinal biomarkers, and obtain atrophy segmentation in OCT, FAF, along with disease progression prediction for GA* - in less than 2 minutes.

The applications are available via Heidelberg Engineering's AppWay on the HEYEX 2 platform. Welcome cutting-edge AI technology to your clinic and enhance patient care.

*Geographic Atrophy AI models available in Research Use Only

This product is intended for

• Clinician
• Medical Doctor
• Ophthalmologist
• Optometrist